MedTrace Logo

Reducing Cardiovascular Risk in Adults With Serious Mental Illness

NCT02451670 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10347

Last updated 2019-11-05

Study results available
· View outcomes & findings →

Summary

This purpose of this study is to adapt, implement and test the ability of a sophisticated point-of-care electronic health record-based clinical decision support that identifies and prioritizes all available evidence-based treatment options to reduce cardiovascular risk in patients with serious mental illness.

Conditions

Interventions

BEHAVIORAL

Prioritized Clinical Decision Support

After entry of blood pressure data at all primary care visits, relevant electronic health record data were automatically extracted, encrypted and processed through Web-based clinical algorithms that determined if the patient met intervention eligibility criteria. In intervention clinics, the rooming staff received a best practice alert and printed patient and primary care provider versions of the clinical decision support that identified evidence-based treatment options for any uncontrolled cardiovascular risk factors and prioritized treatment recommendations based on potential cardiovascular risk reduction. Cardiovascular risk factors addressed in study participants were control of lipids, blood pressure, weight, tobacco, glucose and appropriate aspirin use. In control clinics, rooming staff did not receive a best practice alert and patients and primary care providers did not receive and were not able to access the clinical decision support.

Sponsors & Collaborators

  • Essentia Health

    collaborator OTHER

  • National Institute of Mental Health (NIMH)

    collaborator NIH

  • Park Nicollet Clinic

    collaborator OTHER

  • HealthPartners Institute

    lead OTHER

Principal Investigators

  • Rebecca C Rossom, MD · HealthPartners Institute

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-01-20
Primary Completion
2018-09-19
Completion
2018-09-19

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02451670 on ClinicalTrials.gov